Advent International is contemplating the sale of Zentiva, a generic drugmaker valued at approximately €5 billion ($5.4 billion). The firm, which acquired Zentiva in 2018, is collaborating with Goldman Sachs and PJT Partners to explore potential options, attracting interest from other buyout firms and financial investors eager to enter the sector.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
